Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1995
12/07/1995CA2190598A1 Pharmaceutical composition
12/07/1995CA2187731A1 Activation of growth factors by matrix vesicles
12/07/1995CA2166988A1 Novel dialkoxy-pyridinyl-benzimidazole derivatives
12/07/1995CA2166987A1 Novel substituted benzimidazoles
12/06/1995EP0685486A1 Method of manufacturing lactulose anhydride
12/06/1995EP0685481A2 Alkaloids from mappia foetida, the use thereof and formulations containing them
12/06/1995EP0685479A1 Heterocyclylcarbonyl substituted benzofuranyl- and -thiophenyl-alkanecarboxyclic acid derivatives
12/06/1995EP0685476A1 Benzo(5,6)cycloheptapyridines, compositions and methods of use
12/06/1995EP0685475A1 Amino-benzofuryl-and thienyl-derivatives
12/06/1995EP0685474A1 Oxalylamino-benzofuran- and benzothienyl-derivatives
12/06/1995EP0685473A2 Benzoheterocyclic compounds, as antioxidants
12/06/1995EP0685466A1 3-Heteroaliphatyle-and 3-hetero-(aryle)-aliphatyle-2(1H)-quinolone derivatives
12/06/1995EP0685463A1 Indolin-2-one derivative
12/06/1995EP0685457A1 Glycerol derivative, device and pharmaceutical composition
12/06/1995EP0685235A1 Extracts of piliostigma thonningii, the use thereof and formulations containing them
12/06/1995EP0685234A1 Drug composition containing nucleic acid copolymer
12/06/1995EP0685233A2 Thieno[1,5]benzodiazepine for treating gastrointestinal conditions
12/06/1995EP0685232A2 Cefixim formulation
12/06/1995EP0685231A2 Water-dispersible tablet containing lamotrigine
12/06/1995EP0685230A1 Stable dermatologic preparation containing mycophenolic acid
12/06/1995EP0685229A1 Skin cosmetic composition
12/06/1995EP0685222A1 Cosmetic sunscreening compositions and uses
12/06/1995EP0685169A1 A ruminant feed composition and a method for improving feed efficiency
12/06/1995EP0685160A1 Biocidal compositions
12/06/1995EP0685159A1 Biocidal compositions
12/06/1995EP0685158A1 Biocidal compositions
12/06/1995EP0684973A1 Process for the preparation of a water-dispersible carotenoid preparation in powder form.
12/06/1995EP0684958A1 Polymers containing guanidino groups for use in therapy
12/06/1995EP0684955A1 Nuclear matrix proteins
12/06/1995EP0684953A1 Adenosine kinase inhibitors comprising lyxofuranosyl derivatives
12/06/1995EP0684950A1 Chemical compounds useful in photodynamic therapy and production of laser light
12/06/1995EP0684949A1 Chemical compounds
12/06/1995EP0684948A1 Meso-tetraphenyl porphyrin complex compounds, process for preparing the same and pharmaceuticals containing the same.
12/06/1995EP0684947A1 Amide compounds with pharmacological activity
12/06/1995EP0684945A1 Heterocyclic-substituted alkyl amide acat inhibitors
12/06/1995EP0684944A1 Coupling product obtained from hystamine and an amino acid
12/06/1995EP0684942A1 Method for preparing quinoline carboxylic acids and derivatives thereof
12/06/1995EP0684842A1 Composition for use in the treatment of tumours and the immunization of humans and animals
12/06/1995EP0684841A1 Protein conjugates, compositions containing them and their applications as medicament
12/06/1995EP0684836A1 Combinations of retroviral inhibitors
12/06/1995EP0684827A1 USE OF 26,26,26,27,27,27-HEXAFLUORO-1$g(a),25-DIHYDROXYCHOLECALCIFEROL FOR THE TREATMENT OF CALCIUM METABOLISM DISORDERS
12/06/1995EP0684826A1 Ecdysones used to improve productivity of ruminants
12/06/1995EP0684825A1 Method of preventing or inhibiting fertilization
12/06/1995EP0684823A1 Fibrinogen receptor antagonists
12/06/1995EP0684821A1 Substituted azolone derivatives for treating diseases caused by helicobacter
12/06/1995EP0684820A1 Biologically active 3-substituted oxindole derivatives useful as anti-angiogenic agents
12/06/1995EP0684819A1 Liquid pharmaceutical compositions based on ibuprofen
12/06/1995EP0684818A1 Method of reversing resistance of hiv-1 strains to zidovudine
12/06/1995EP0684817A1 Cancer treatment
12/06/1995EP0684816A1 5-ht 2? receptor antagonist compositions useful in treating venous conditions
12/06/1995EP0684811A1 Use of diglycerine esters against skin impurities
12/06/1995EP0684809A1 Compositions and methods for promoting hair growth
12/06/1995EP0684765A1 Treating alopecia by administering 5-alpha-reductase inhibiting compounds
12/06/1995EP0684764A1 Treatment of androgen-associated baldness using antisense oligomers
12/06/1995EP0647131B1 Dermatological agent for aiding oxygen transport in the skin
12/06/1995EP0593478B1 Leukotriene b 4 antagonists
12/06/1995EP0588850B1 N-hydroxyurea derivatives which inhibit lipoxygenase
12/06/1995EP0575429B1 Treatment of cognitive disorders
12/06/1995EP0566566B1 Compositions and methods for alleviating menopausal symptoms
12/06/1995EP0544819B1 Indole derivatives which inhibit leukotriene biosynthesis
12/06/1995EP0520021B1 Pharmaceutical compositions
12/06/1995EP0500847B1 Treatment of obesity with an alpha-2-adrenergic agonist and a growth hormone releasing peptide
12/06/1995EP0495106B1 Osteogenesis promoter
12/06/1995EP0491814B1 Tetracyclic imidazoquinazoline derivatives, preparation and pharmaceutical compositions
12/06/1995EP0445255B1 Treatment of conditions and disease
12/06/1995EP0423318B1 Use of c5-c6 esters for the manufacture of a therapeutic composition for cholesterol gallstone dissolution
12/06/1995EP0394314B2 Multiple step entrapment/loading procedure for preparing lipophilic drug-containing liposomes
12/06/1995CN1113074A Aqueous composition
12/06/1995CN1112932A Lactic-acid-containing cyclic depsipeptides having 18 ring atoms as endoparasiticidal agents, and pral agentr their preparation
12/06/1995CN1112928A Novel method for preparation and/or purification of clavulanic acid or pharmaceutical salt or ester of same
12/06/1995CN1112926A 1,3 substituted condensed pyrazole compound, the application and prepn. method
12/06/1995CN1112920A Organopathy preventing, curing or ameliorating agent
12/06/1995CN1112919A Pharmaceutical agents for the treatment of myocardial reperfusion injury and myocardial stunning
12/06/1995CN1112918A Fluorinated vitamin D3 derivative
12/06/1995CN1112914A Process for the preparation of allyl quinone derivatives, and intermediates
12/06/1995CN1112835A Compound immune antibiotic
12/06/1995CN1112825A Minimizing trichomadesis with anti-fungus compound and halogeno-anti-bacteria compound
12/06/1995CN1030452C Preparation of novel 2-aminopyrimidinone derivatives
12/05/1995USRE35112 Administering phenyl butyl nitrone or derivative in carrier in dosage to prevent or reverse oxidative central nervous system tissue damage
12/05/1995US5473100 Hydroxamic acid derivative
12/05/1995US5473096 Substituted benzoate derivatives
12/05/1995US5473079 Process for preparing 2-arylbenzimidazole-5-sulfonic acids
12/05/1995US5473077 4-aminopyrrolidine-2,4-substitude independently with carboxylic acid or 5-tetrazolyl for treating nervous system disorders and psychological disorders
12/05/1995US5473076 Enantiomerically pure intermediates for (quinolin-2-yl-methoxy) phenylacetic acids
12/05/1995US5473074 Adenosine diphosphoribose polymerase binding nitroso aromatic compounds useful as retroviral inactivating agents, anti-retroviral agents and anti-tumor agents-54
12/05/1995US5473072 Process for the preparation of high purity buspiron and the hydrochloride thereof
12/05/1995US5473071 Process for the preparation of fused pyridine compounds
12/05/1995US5473070 Substituted long chain alcohol xanthine compounds
12/05/1995US5473067 For controlling ocular hypertension
12/05/1995US5473063 Reacting 2,3-epoxy-butanediol/1,4-/(having protected hydroxyl groups) with an alpha allylic nucleophile yields 2-hydroxy-3-allyl-1,4-butanediol, then oxidatively cleaving the double bond, cyclization, halogenation, acetylation or oxyalkylation
12/05/1995US5473057 Anticarcinogenic agents
12/05/1995US5472985 Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
12/05/1995US5472983 Benzamide-containing pharmaceutical compositions
12/05/1995US5472982 Emulsified external treatment composition containing diclofenac sodium
12/05/1995US5472980 Parental administration of pyruyate precursors
12/05/1995US5472979 1,2,3,4-tetrahydronaphthalene compounds
12/05/1995US5472978 Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
12/05/1995US5472977 Administering 3,4-(diphenyl)chromans
12/05/1995US5472976 Poly 4-aminopyrrole-2-carboxyamide derivatives, and pharmaceutical compositions which contain them
12/05/1995US5472975 Cognition activators, antidepressants
1 ... 6962 6963 6964 6965 6966 6967 6968 6969 6970 6971 6972 6973 6974 6975 6976 6977 6978 6979 6980 6981 6982 ... 7860